What is the trade name of Erlotinib? Can it be purchased in China?

The main trade name of Erlotinib (Erlotinib) in the domestic market is "Tarceva". As a commonly used targeted anti-cancer drug, Tarceva is mainly used to treat malignant tumors such as non-small cell lung cancer and pancreatic cancer. This drug inhibits the activity of epidermal growth factor receptor (EGFR) tyrosine kinase, thereby blocking the signal transduction of tumor cells and achieving the effect of inhibiting tumor growth and spread.

At present, erlotinib has been officially launched in China and has been included in the national medical insurance directory, which allows patients to purchase and use it at a more favorable price. According to the specific policies of different regions and hospitals, the price of erlotinib is roughly around a few hundred yuan, and the medical insurance reimbursement ratio and actual costs will vary. When purchasing, patients are advised to consult the local hospital pharmacy to learn about the latest prices and reimbursement policies to obtain the optimal medication plan.

In addition to domestic trade names and supply channels, erlotinib also has original drugs and multiple generic versions in foreign markets. In terms of price, foreign original drugs are usually more expensive, while Laotian generic drugs are priced at about 400 yuan due to their lower production costs, making them an economical and affordable choice for many patients. It should be noted that when purchasing overseas drugs, patients should confirm the quality and legality of the drugs and avoid purchasing fake and shoddy products.

Overall, as a targeted therapy drug with mature clinical application, the domestic launch and medical insurance coverage of erlotinib have greatly facilitated the treatment needs of patients. Patients should strictly follow the doctor's instructions during medication, choose purchasing channels reasonably, and conduct regular follow-up visits to monitor the therapeutic effects and drug safety to ensure the scientificity and effectiveness of the treatment.

Reference:https://en.wikipedia.org/wiki/Erlotinib